Table 3 Serum concentrations of biochemical variables in monozygotic twin adults with and without cholecalciferol supplementation.
CG (n = 45) | SG (n = 45) | CG (T60) × SG (T60) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
T0 | T60 | Effect size | p value | T0 | T60 | Effect size | p value | Effect size | p value | |
*25 (OH) D, ng/mL | 32.7 (27.3–43.9) | 34.4 (26.9–39.3) | 0.050 | 0.382 | 30.7 (26.3–33.6) | 50.6 (40.3–56.1) | 1.763 | < 0.001 | 1.422 | < 0.001 |
Total proteins, g/dL | 7.4 (6.9–8.1) | 7.3 (6.5–7.9) | 0.469 | 0.189 | 7.3 (7.0–8.1) | 7.3 (6.5–7.7) | 0.409 | 0.138 | – | 0.729* |
Glucose, mg/dL | 86.0 (79.0–97.0) | 84.0 (79.0–93.0) | 0.048 | 0.397 | 87.0 (79.0–94.5) | 87.5 (82.0–91.0) | 0.166 | 0.069 | 0.090 | 0.735 |
Total cholesterol, mg/dL | 164.0 (143.0–188.0) | 165.0 (144.0–182.0) | 0.281 | 0.022 | 165.0 (138.5–185.5) | 155.0 (129.0–173.5) | 0.431 | 0.003 | 0.237 | 0.236 |
HDL cholesterol, mg/dL | 38.0 (30.0–51.0) | 45.0 (33.0–57.0) | 0.414 | 0.076 | 38.0 (31.5–51.0) | 41.0 (34.5–52.3) | 0.349 | 0.080 | 0.026 | 0.886 |
Triglycerides, mg/dL | 80.0 (64.5–118.5) | 74.0 (57.0–92.0) | 0.199 | 0.018 | 83.0 (65.5–118.0) | 90.0 (66.8–114.8) | 0.157 | 0.300 | 0.127 | 0.224 |
ALT, U/L | 19.0 (12.5–31.0) | 17.0 (12.0–22.0) | 0.246 | 0.058 | 17.0 (11.5–31.0) | 14.5 (11.0–20.8) | 0.391 | 0.017 | 0.137 | 0.099 |
AST, U/L | 20.0 (17.0–24.0) | 19.0 (14.0–23.0) | 0.184 | 0.314 | 19.0 (16.0–28.0) | 18.5 (15.8–25.3) | 0.372 | 0.070 | 0.098 | 0.477 |
Uric acid, mg/dL | 4.0 (3.0–5.2) | 3.7 (2.9–4.2) | 0.312 | 0.007 | 4.0 (3.1–5.1) | 3.6 (3.0–4.9) | 0.362 | 0.003 | 0.024 | 0.985 |
Creatinine, mg/dL | 0.9 (0.8–1.0) | 0.8 (0.7–1.1) | 0.349 | 0.031 | 0.9 (0.8–1.1) | 0.8 (0.7–1.1) | 0.278 | 0.039 | 0.034 | 0.856 |